Robert Stoehr - Concepedia

Author

Robert Stoehr

Friedrich-Alexander-Universität Erlangen-Nürnberg ORCID

Also Known As

Bernd Wullich, C G Stoehr, C. G. Stoehr, C.G. Stoehr, Christine G Stoehr, Christine G. Stoehr, Christine Stoehr, Dawid Murawa, Eric Baudin, Glenn Bubley

185

Publications

69.3K

Citations

H-Index

Concepts

All Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg University of Regensburg Universitätsklinikum Erlangen Comprehensive Cancer Center Erlangen RWTH Aachen University

About

Robert Stoehr is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	6.1K
2	Engineering	3	3	1.3K
3	Public Health	2	2	3.8K
4	Anatomy	1	1	56
5	Biostatistics	1	1	3.8K

Robert Stoehr

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Jianfang Liu, Tara M. Lichtenberg, Katherine A. Hoadley, Cell Prognostic BiomarkersSurgical OncologyHealth InformaticsMedicineCancer Management	2018	3.8K
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients André Kahles, Kjong-Van Lehmann, Nora C. Toussaint, Cancer Cell	2018	934
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples Han Chen, Chunyan Li, Xinxin Peng, Cell	2018	333
WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer Christoph Wissmann, Peter J. Wild, Simone Kaiser, The Journal of Pathology EngineeringPathologyCancer BiologyTumor BiologyChip Hybridization	2003	332
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma Edgar Dahl, Frank Wiesmann, Matthias Woenckhaus, Oncogene Tumor BiologyUrologyGenitourinary CancerMedicineRenal Pathology	2007	136
Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Arndt Hartmann, Livia Zanardo, Tina Bocker Edmonston, PubMed Frequent Microsatellite InstabilityUrologyTumoral PathologyMsi TumorsGenitourinary Cancer	2002	125
Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes Abbas Agaimy, Florian Haller, Judith Frohnauer, Modern Pathology Tumor BiologyOncologyPancreatic CancerRhabdoid CarcinomaMedicine	2014	110

Page 1